Rheumatology Advisor—April 3, 2018
Rheumatology Advisor reporter Tori Rodriguez writes on using statins for cardiovascular risk reduction in rheumatoid arthritis patients.
She interviews Jane E. Salmon, MD, rheumatologist at HSS, who explains that statins have pleiotropic effects, both lipid lowering and anti-inflammatory.
"Although the risk for CVD [cardiovascular disease] in [people with RA] is elevated, similar to patients with diabetes, CV risk management is generally not implemented. Attention to comorbidities such as hypertension, hyperlipidemia, and smoking is essential [for people with] RA. Control of RA disease activity is also likely to attenuate or decrease CVD risk in RA," says Dr. Salmon.
Read the full article at RheumatologyAdvisor.com.